Jiateng Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jiateng Zhang has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Hua Zhu
Department of Gastroenterology, Yancheng Third People's Hospital, Yancheng, China
1 shared publicationJun Zhou
1 shared publication- Peng Li
Institute of Precision Guidance and Control, School of Astronautics, Northwestern Polytechnical University, Xian, China
1 shared publication Ruidong Xu
1 shared publication- Tao Zhang
Department of Clinical Veterinary Medicine, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, China
1 shared publication - Tu Hong
Chongqing Co-core Intelligent Technology Research Institute Co. Ltd. , Chongqing, 400000 China
1 shared publication
Latest Publications
- Open Access
- 25 July 2022
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 10, 954721
Recent advances of eosinophils and its correlated diseases
Eosinophils are differentiated by bone marrow multipotent progenitor cells and are further released into peripheral blood after maturation. Human eosinophils can exhibit unique multi-leaf nuclear morphology, which are filled with cytoplasmic granules that contain cytotoxicity and immune regulatory proteins. In recent years, many studies focused on the origin, differentiation and development process of eosinophils. It has been discovered that the eosinophils have the regulatory functions of innate and adaptive immunity, and can also function in several diseases, including asthma, chronic obstructive pulmonary diseases, acute respiratory distress syndrome, malignant tumors and so on. Hence, the role and effects of eosinophils in various diseases are emphasized. In this review, we comprehensively summarized the development and differentiation process of eosinophils, the research progress of their related cytokines, diseases and current clinical treatment options, and discussed the potential drug target, aiming to provide a theoretical and practical basis for the clinical prevention and treatment of eosinophil-related diseases, especially respiratory diseases. To conclude, the guiding significance of future disease treatment is proposed based on the recent updated understandings into the cell functions of eosinophils.
- 25 July 2022
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 10, 954721
Open AccessRecent advances of eosinophils and its correlated diseases
Eosinophils are differentiated by bone marrow multipotent progenitor cells and are further released into peripheral blood after maturation. Human eosinophils can exhibit unique multi-leaf nuclear morphology, which are filled with cytoplasmic granules that contain cytotoxicity and immune regulatory proteins. In recent years, many studies focused on the origin, differentiation and development process of eosinophils. It has been discovered that the eosinophils have the regulatory functions of innate and adaptive immunity, and can also function in several diseases, including asthma, chronic obstructive pulmonary diseases, acute respiratory distress syndrome, malignant tumors and so on. Hence, the role and effects of eosinophils in various diseases are emphasized. In this review, we comprehensively summarized the development and differentiation process of eosinophils, the research progress of their related cytokines, diseases and current clinical treatment options, and discussed the potential drug target, aiming to provide a theoretical and practical basis for the clinical prevention and treatment of eosinophil-related diseases, especially respiratory diseases. To conclude, the guiding significance of future disease treatment is proposed based on the recent updated understandings into the cell functions of eosinophils.